Paul Rogers
Clinical Cardiac Electrophysiology · New Orleans, LANPI 1598926420
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Biotronik Inc. at 41.7% of the total. Reporting peaked in 2023 at $6,043 and has fallen 72.6% since, to $1,658 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in LA, where the typical reported total is $18,132.
Across 130 payments — averaging $138.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$8K
- Abbott$5K
- Medtronic$2K
- Boston Scientific$2K
- Impulse Dynamics (USA) Inc.$321
- Biosense Webster, Inc.$291
- plus $794 from 10 others
Across 13 payments — averaging $4498.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$39K
- Impulse Dynamics (USA) Inc.$19K
What the payments were for
- Speaking & faculty fees$6,90638%
- Travel & lodging$3,89222%
- Food & beverage$7,22140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 28 | $7,509 |
| Abbott | 48 | $5,258 |
| Medtronic(2 entities) | 10 | $2,218 |
| Boston Scientific | 9 | $1,629 |
| Impulse Dynamics (USA) Inc. | 3 | $321 |
| Biosense Webster, Inc. | 4 | $291 |
| Johnson & Johnson | 11 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $188 |
| Philips North America LLC | 4 | $162 |
| Baxter Healthcare | 3 | $114 |
| Pfizer | 2 | $34 |
| Novo Nordisk | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $22 |
| Cook Medical LLC | 1 | $18 |
| Bardy Diagnostics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GALLANT$2,149
- ENSITE PRECISION$736
- Selectra$515
- Acticor 7 VR-T DX$384
- OPTIMIZER$299
- Confirm Rx$286
- Solia$237
- EnSite Precision Cardiac Mapping System$225
- Micra$174
- Ensite Cardiac Mapping System$168
- OMNIASECURE MRI SURESCAN$152
- COBALT DR MRI SURESCAN$150
- Watchman$149
- Arctic Front$145
- Accent Pacemaker$135
- WATCHMAN Access System$135
- Quadra Assura CRT Defibrillator$125
- Carto 3$123
- ENSITE$121
- AMPLATZER$120
How this compares
$18,019 in reported general payments places this provider in the 45th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
See all clinical cardiac electrophysiology providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,281 | $1,118,585 |
| XareltoRivaroxaban | 288 | $268,583 |
| MultaqDronedarone Hcl | 194 | $224,853 |
| Flecainide Acetate | 448 | $14,575 |
| Metoprolol Succinate | 716 | $9,386 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 26 | $7,221 |
| Propafenone Hcl ErPropafenone Hcl | 28 | $6,061 |
| Amiodarone Hcl | 291 | $5,296 |
| Dofetilide | 75 | $4,687 |
| Verapamil ErVerapamil Hcl | 41 | $2,823 |
| Verapamil SrVerapamil Hcl | 29 | $2,612 |
| SotalolSotalol Hcl | 122 | $2,089 |
| Dilt-XrDiltiazem Hcl | 42 | $990 |
| Metoprolol Tartrate | 160 | $918 |
| Mexiletine Hcl | 12 | $908 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $1,118,5851,281 claims |
| Johnson & JohnsonXarelto | $189 | $268,583288 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 43 clinical cardiac electrophysiology providers in Louisiana.
Other clinical cardiac electrophysiology in New Orleans
- Nassir MarroucheNew Orleans$498K
- Sammy KhatibNew Orleans$115K
- Paul LelorierNew Orleans$101K
- Adil YousufNew Orleans$101K
- Michael BernardNew Orleans$59K
- Dedric ClarkeNew Orleans$51K
- Glenn PolinNew Orleans$41K
- Colleen JohnsonNew Orleans$26K
- Omar KreidiehNew Orleans$26K
- Freddy Abi-SamraNew Orleans$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.